Medtronic PLC

MDT Healthcare Medical Devices

Medtronic PLC’s revenue for fiscal 2026 (year ended April 2026) was $36.4 billion, up 8.43% from fiscal 2025. In the quarter to July 2026, revenue grew 13.7%, EPS grew 42.0%, free cash flow grew 120.9% and total debt fell 1.59%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for three, operating cash flow growth for three.

94.75 0.70 −0.73%
Market cap
$122.1B
P/E
23.2×
Fwd P/E
18.7×
Dividend yield
3.02%
F-score
7/9
Altman Z
2.73
Beneish M
−2.58
Dividend safety
61/100
Jul '26 Apr '26 Jan '26 Oct '25 Older periods
Piotroski F-Score
8 7 7 8

+8 more TTM periods

ROE
10.57% 9.77% 9.34% 9.77%
ROA
5.68% 5.20% 5.08% 5.25%
ROIC
6.04% 5.87% 5.47% 5.58%
Return on Tangible Assets
26.07% 23.37% 21.20% 22.45%
Average Days of Receivables
61.81 66.68 65.41 67.09
Free Cash Flow per Share
4.79 4.23 4.22 4.06
Free Cash Flow
6,132.00 5,426.00 5,410.00 5,206.00
Capital Expenditures
(1,903.00) (1,904.00) (1,875.00) (1,907.00)
Other line items
Cash ROIC
6.98% 6.22% 6.32% 6.03%
Accounts Receivable Turnover
5.95 5.53 5.69 5.50
Accounts Payable Turnover
5.00 5.00 5.14 4.84
Inventory Turnover
2.17 2.23 2.09 2.06
Average Days of Payables
74.88 75.86 75.20 78.59
Days of Inventory on Hand
172.69 170.75 184.68 187.45
Tax Rate
(0.20) (0.21) (0.17) (0.16)
Research and Development Expense of Revenue
7.77% 7.90% 8.13% 8.17%
Selling, General and Administrative Expense of Revenue
32.43% 32.41% 32.26% 32.25%
Share Based Compensation of Revenue
1.32% 1.26% 1.27% 1.31%
Interest Coverage
9.36 9.04 8.47 8.75
Operating CF/Net income
1.54 1.53 1.58 1.49
Depreciation/Fixed assets
0.39 0.40 0.43 0.42
Capex/Depreciation
(0.65) (0.64) (0.61) (0.63)
Revenue per Share
29.33 28.37 27.66 27.11
Operating CF per Share
6.28 5.72 5.68 5.55
Capex per Share
(1.49) (1.49) (1.46) (1.49)
Capex to Sales
0.05 0.05 0.05 0.05

Fold the line items

Columns are period end dates